LIVE: House hearing on Dengvaxia

This is AI generated summarization, which may have errors. For context, always refer to the full article.

LIVE: House hearing on Dengvaxia
Watch the hearing live on Rappler

MANILA, Philippines – The House of Representatives is investigating the controversy surrounding the purchase of P3.5 billion worth of dengue vaccine doses for public school students in the country.

Analysis of clinical data showed Sanofi Pasteur’s Dengvaxia poses more risks for people who have not been infected by the virus before immunization.

More than 700,000 Filipino children in Luzon have been given the dengue vaccine under the government’s immunization program, according to the Department of Health. –

Previous hearings

February 5, 2018

Add a comment

Sort by

There are no comments yet. Add your comment to start the conversation.

Summarize this article with AI

How does this make you feel?

Download the Rappler App!